Journal ArticleJ Gen Intern Med · December 9, 2025
BACKGROUND: When patients with multimorbidity (≥ 2 chronic diseases) are diagnosed with cancer, their adherence to non-cancer medications declines. Nonadherence in this patient population has been linked to an increased risk of disease progression, hospita ...
Full textLink to itemCite
Journal ArticleBMJ Lead · December 9, 2025
BACKGROUND: Despite the widespread availability of many vaccines and health providers' favourable attitudes towards vaccines, suboptimal immunisation rates persist worldwide. This study investigates the impact of presumptive (opt-out) communication trainin ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 13, 2025
BACKGROUND: Financial toxicity in oncology, defined as the economic burden and psychosocial distress of cancer care, has been associated with poor clinical outcomes. Despite high projected treatment costs, data on financial toxicity in patients with sarcom ...
Full textLink to itemCite
Journal ArticleJ Gen Intern Med · November 3, 2025
BACKGROUND: Over one-quarter of adults have multimorbidity. Patients with multimorbidity are more likely to struggle to afford their care than patients without multimorbidity, but their experiences with financial strain have not been fully described. OBJEC ...
Full textLink to itemCite
Journal ArticleCancer Epidemiol · October 2025
BACKGROUND: Cancer presents a disproportionate burden, particularly among individuals from low socioeconomic status neighborhoods. Disparities in outcomes persist, influenced by limited access to healthcare services, cultural barriers, and neighborhood soc ...
Full textLink to itemCite
Journal ArticleDiabetes Care · September 1, 2025
OBJECTIVE: Bariatric surgery lowers the risk of developing microvascular and macrovascular complications of type 2 diabetes, but it is unclear whether it also lowers long-term health expenditures in this population. RESEARCH DESIGN AND METHODS: In a retros ...
Full textLink to itemCite
Journal ArticleJ Med Internet Res · July 29, 2025
BACKGROUND: Web-based crowdfunding is commonly used to defray medical expenses, but it is not fully known which factors determine fundraising success. Previous studies have usually focused on a single disease category at a time or a small number of mutuall ...
Full textLink to itemCite
Journal ArticleJ Gen Intern Med · July 7, 2025
BACKGROUND: Polypharmacy (≥ 5 medications) and potentially inappropriate medications (PIM; per Beers criteria) are common in midlife. Polypharmacy and PIM use are associated with poor physical function and adverse health outcomes in older age, but the asso ...
Full textLink to itemCite
Journal ArticleJCO Oncol Pract · May 9, 2025
PURPOSE: Many cancer survivors consume alcohol above recommended limits, increasing their risk of recurrence, second cancers, and cancer-related mortality. Alcohol screening, brief intervention, and referral to treatment (SBIRT) is a guideline-recommended ...
Full textLink to itemCite
Journal ArticleAnn Intern Med · March 2025
BACKGROUND: Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) differ in their effects on body weight and risk for reoperation. However, it is unclear whether long-term health expenditures differ by procedure type in patients with diabetes. OBJECT ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · February 4, 2025
As expensive therapeutics rise to the fore of heart failure management, out-of-pocket (OOP) medication costs have become increasingly relevant to patient care. Prescription medication costs influence medical decision-making and affect adherence. Yet, indiv ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · January 2025
BACKGROUND: Guideline-directed medical therapy for heart failure (HF) with reduced ejection fraction can entail high out-of-pocket (OOP) costs, prompting concerns about financial toxicity and access. OOP costs are generally unavailable during encounters. T ...
Full textLink to itemCite
Journal ArticleSage Open Aging · January 1, 2025
Purpose: The benefits and harms of medical interventions shift as patients age, calling for re-evaluation of each intervention’s appropriateness and alignment with patients’ preferences. Continued use of medical interventions when harms outweigh benefits i ...
Full textCite
Journal ArticleJAMA Health Forum · December 6, 2024
IMPORTANCE: Medicare finances health care for most US patients with end-stage kidney disease (ESKD), regardless of age. Medicare enrollment may have slowed for patients with incident ESKD who gained access to new private insurance options with the 2014 pas ...
Full textLink to itemCite
Journal ArticleAnn Surg · December 1, 2024
OBJECTIVE: To compare expenditures between surgical and matched nonsurgical patients in a retrospective cohort study. BACKGROUND: Bariatric surgery leads to substantial improvements in weight and weight-related conditions, but prior literature on postsurgi ...
Full textLink to itemCite
Journal ArticleBMC Med Res Methodol · November 13, 2024
BACKGROUND: Methods for matching in longitudinal cohort studies, such as sequential stratification and time-varying propensity scores, facilitate causal inferences in the context of time-dependent treatments that are not randomized where patient eligibilit ...
Full textLink to itemCite
Journal ArticleJ Am Geriatr Soc · August 2024
BACKGROUND: The use of potentially inappropriate medications (PIMs) is associated with increased risk of hospitalizations and emergency room visits and varies by racial and ethnic subgroups. Medicare's nationwide medication therapy management (MTM) program ...
Full textLink to itemCite
Journal ArticleJAMA Health Forum · May 3, 2024
IMPORTANCE: Comprehensive medication reviews (CMRs) are offered to qualifying US Medicare beneficiaries annually to optimize medication regimens and therapeutic outcomes. In 2016, Medicare adopted CMR completion as a Star Rating quality measure to encourag ...
Full textLink to itemCite
Journal ArticleCurr Atheroscler Rep · December 2023
PURPOSE OF REVIEW: Pharmacoequity refers to the goal of ensuring that all patients have access to high-quality medications, regardless of their race, ethnicity, gender, or other characteristics. The goal of this article is to review current evidence on dis ...
Full textOpen AccessLink to itemCite
Journal ArticleJAMA Netw Open · September 1, 2022
IMPORTANCE: Medicare finances health care for most US patients with end-stage kidney disease (ESKD), regardless of age. The 2011 Medicare prospective payment system (PPS) for dialysis reduced reimbursement for hemodialysis, and the 2014 Patient Protection ...
Full textLink to itemCite
Journal ArticlePatient Educ Couns · August 2022
OBJECTIVES: Clinicians increasingly believe they should discuss costs with their patients. We aimed to learn what strategies clinicians, clinic leaders, and health systems can use to facilitate vital cost-of-care conversations. METHODS: We conducted focus ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · November 1, 2021
IMPORTANCE: One-third of US residents have trouble paying their medical bills. They often turn to their physicians for help navigating health costs and insurance coverage. OBJECTIVE: To determine whether physicians can accurately estimate out-of-pocket exp ...
Full textLink to itemCite
Journal ArticleJAMA Health Forum · November 2021
IMPORTANCE: The dialysis industry is highly concentrated, with large dialysis organizations now providing dialysis for more than 85% of patients with kidney failure in the United States. In 2011, Medicare introduced a new Prospective Payment System (PPS) f ...
Full textOpen AccessLink to itemCite
Journal ArticleMed Care Res Rev · June 2021
Peritoneal dialysis (PD), a home-based treatment for kidney failure, is associated with similar mortality, higher quality of life, and lower costs compared with hemodialysis. Yet <10% of patients receive PD. Access to this alternative treatment, vis-à-vis ...
Full textLink to itemCite
Journal ArticleMed Care · February 1, 2021
BACKGROUND: Prior studies have shown peritoneal dialysis (PD) patients to have lower or equivalent mortality to patients who receive in-center hemodialysis (HD). Medicare's 2011 bundled dialysis prospective payment system encouraged expansion of home-based ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · November 2, 2020
IMPORTANCE: Biased patient behavior negatively impacts resident well-being. Data on the prevalence and frequency of these encounters are lacking and are needed to guide the creation of institutional trainings and policies to support trainees. OBJECTIVE: To ...
Full textLink to itemCite
Journal ArticleSemin Dial · November 2020
Caring for patients with end-stage kidney disease (ESKD) in the United States is challenging, due in part to the complex epidemiology of the disease's progression as well as the ways in which care is delivered. As CKD progresses toward ESKD, the number of ...
Full textLink to itemCite
Journal ArticleJ Gen Intern Med · May 2020
BACKGROUND: Short-term health care costs following completion of health risk assessments and coaching programs in the VA have not been assessed. OBJECTIVE: To compare VA health care expenditures among veterans who participated in a behavioral intervention ...
Full textLink to itemCite
Journal ArticleClin J Am Soc Nephrol · December 6, 2019
BACKGROUND AND OBJECTIVES: Peritoneal dialysis (PD) for ESKD is associated with similar mortality, higher quality of life, and lower costs compared with hemodialysis (HD), but has historically been underused. We assessed the effect of the 2011 Medicare pro ...
Full textLink to itemCite
Journal ArticleN C Med J · 2018
Out-of-pocket spending continues to increase, particularly in cancer care. High out-of-pocket expenditures are associated with increased psychosocial distress, lower adherence, and higher mortality. In order to improve cancer-related outcomes, we must come ...
Full textLink to itemCite
Journal ArticleHIV Med · July 2017
OBJECTIVES: Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) is approved for pre-exposure prophylaxis (PrEP) against HIV infection. Adherence is critical for the success of PrEP, but current adherence measurements are inadequate for real-time adherenc ...
Full textLink to itemCite
Journal ArticlePLoS One · 2016
BACKGROUND: Although cytogenetics-based prognostication systems are well described in acute myeloid leukemia (AML), overall survival (OS) remains highly variable within risk groups. An integrated genetic prognostic (IGP) model using cytogenetics plus mutat ...
Full textLink to itemCite
Journal ArticleDiagn Microbiol Infect Dis · September 2015
We assessed whether expectorated sputum samples are ordered according to national guidelines and the impact of culture results on patient management. Overall, guidelines for ordering sputum samples were followed for 23% (18/78) of patients. Results affecte ...
Full textLink to itemCite
Journal ArticleAm J Clin Pathol · February 2015
OBJECTIVES: Mantle cell lymphoma in situ (MCLIS) consists of immunophenotypically defined but histologically inapparent neoplastic cells restricted to narrow mantle zones, without expansion or invasion beyond the mantle zone. We report a unique case of MCL ...
Full textLink to itemCite
Journal ArticleAcad Radiol · December 2014
RATIONALE AND OBJECTIVES: To understand the reasons leading to potentially inappropriate management of imaging findings concerning for malignancy and identify optimal methods for communicating these findings to providers. MATERIALS AND METHODS: We identifi ...
Full textLink to itemCite
Journal ArticleAIDS · January 2, 2012
OBJECTIVE: To determine the component costs of care to optimize treatment with limited resources. DESIGN: We used the Cost-Effectiveness of Preventing AIDS Complications Model of HIV disease and treatment to project life expectancy and both undiscounted an ...
Full textLink to itemCite
Journal ArticleMalar J · April 29, 2011
BACKGROUND: The World Health Organization (WHO) recommends using insecticide-treated mosquito nets (ITNs) and intermittent preventive treatment with sulphadoxine-pyrimethamine (IPT-SP) to prevent malaria in sub-Saharan Africa. Data on IPT-SP coverage and f ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · April 2011
BACKGROUND: Adherence is a strong determinant of viral suppression with antiretroviral therapy (ART) but measuring it is challenging. Medication delivery can be measured accurately in settings with computerized prescription databases. We studied the associ ...
Full textLink to itemCite
Journal ArticleAIDS Res Ther · March 10, 2011
BACKGROUND: Our goal was to illustrate a method for making indirect treatment comparisons in the absence of head-to-head trials, by portraying the derivation of published efficacies for prophylaxis regimens of HIV-related opportunistic infections. RESULTS: ...
Full textLink to itemCite
Journal ArticlePLoS One · October 1, 2010
BACKGROUND: In France, roughly 40,000 HIV-infected persons are unaware of their HIV infection. Although previous studies have evaluated the cost-effectiveness of routine HIV screening in the United States, differences in both the epidemiology of infection ...
Full textLink to itemCite
Journal ArticleCurr Opin HIV AIDS · May 2010
PURPOSE OF REVIEW: In the face of increasing economic constraints, it is critically important to evaluate how best to utilize available resources. In this article, we review the growing number of cost-effectiveness analyses of HIV treatment with antiretrov ...
Full textLink to itemCite
Journal ArticleHIV Clin Trials · 2010
PURPOSE: ACTG A5164 demonstrated that early antiretroviral therapy (ART) in HIV-infected patients with acute opportunistic infections (OIs) reduced death and AIDS progression compared to ART initiation 1 month later. We project the life expectancies, costs ...
Full textLink to itemCite
Journal ArticleAntivir Ther · 2010
BACKGROUND: International trials have shown that CD4+ T-cell-guided structured treatment interruptions (STI) of antiretroviral therapy (ART) lead to worse outcomes than continuous treatment. We simulated continuous ART and STI strategies with higher CD4+ T ...
Full textLink to itemCite
Journal ArticlePLoS Curr · October 26, 2009
Capitalizing on available data, we used a decision model to estimate the clinical and economic outcomes associated with early initiation of treatment with neuraminidase inhibitors in all patients with influenza-like illnesses ( ILI ) (systematic strategy) ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · March 15, 2009
BACKGROUND: The combination of tenofovir and emtricitabine shows promise as HIV preexposure prophylaxis (PrEP). We sought to forecast clinical, epidemiologic, and economic outcomes of PrEP, taking into account uncertainties regarding efficacy, the risks of ...
Full textLink to itemCite